ライフサイエンスコーパス: endoscopic retrograde cholangiopancreatography

1 endoscopies, 1109 lower endoscopies, and 58 endoscopic retrograde cholangiopancreatographies).

2 ings correlated with those at helical CT and endoscopic retrograde cholangiopancreatography.

3 elial recognition of T cells obtained during endoscopic retrograde cholangiopancreatography.

4 ), uSEMS (n = 75), or pcSEMS (n = 71) during endoscopic retrograde cholangiopancreatography.

5 quiring expertise in both endosonography and endoscopic retrograde cholangiopancreatography.

6 liary anastomotic stricture was confirmed by endoscopic retrograde cholangiopancreatography.

7 who failed to have a biliary stent placed by endoscopic retrograde cholangiopancreatography.

8 c techniques for attaining biliary access at endoscopic retrograde cholangiopancreatography.

9 lth (NIH) State-of-the-Science Conference on endoscopic retrograde cholangiopancreatography.

10 ry sclerosing cholangitis in comparison with endoscopic retrograde cholangiopancreatography.

11 here is increasing pediatric experience with endoscopic retrograde cholangiopancreatography.

12 olving areas include chemoprevention of post-endoscopic retrograde cholangiopancreatography acute pan

13 Chemoprevention of post-endoscopic retrograde cholangiopancreatography acute pan

14 rred for elective direct cholangiography (45 endoscopic retrograde cholangiopancreatography and 1 per

15 Pancreatic ductal anatomy was defined using endoscopic retrograde cholangiopancreatography and categ

16 Timing of endoscopic retrograde cholangiopancreatography and outco

17 ts have poor correlation with the results of endoscopic retrograde cholangiopancreatography and the s

18 s included angiography, computed tomography, endoscopic retrograde cholangiopancreatography, and magn

19 n of patients at risk for pancreatitis after endoscopic retrograde cholangiopancreatography, and refi

20 es for use in endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography are just

21 of the current investigations in therapeutic endoscopic retrograde cholangiopancreatography as well a

22 The risks of pancreatitis after endoscopic retrograde cholangiopancreatography as well a

23 mphasizes the broadening therapeutic role of endoscopic retrograde cholangiopancreatography as well a

24 ples from 50 patients undergoing therapeutic endoscopic retrograde cholangiopancreatography at univer

25 Endoscopic retrograde cholangiopancreatography brushings

26 ooled data demonstrate that balloon-assisted endoscopic retrograde cholangiopancreatography can achie

27 at rectal diclofenac given immediately after endoscopic retrograde cholangiopancreatography can reduc

28 In many cases, therapeutic endoscopic retrograde cholangiopancreatography can take

29 f using abdominal computed tomography scans, endoscopic retrograde cholangiopancreatography, carcinoe

30 Endoscopic retrograde cholangiopancreatography confirmed

31 Pediatric endoscopic retrograde cholangiopancreatography continues

32 Timing of endoscopic retrograde cholangiopancreatography does not

33 omies (VLCs), 2 open cholecystectomies and 4 endoscopic retrograde cholangiopancreatography/endoscopi

34 The authors reviewed the results of endoscopic retrograde cholangiopancreatography (ERCP) an

35 tic use at 1 year were increased by previous endoscopic retrograde cholangiopancreatography (ERCP) an

36 Subjects undergoing elective endoscopic retrograde cholangiopancreatography (ERCP) an

37 t pancreatitis who were scheduled to undergo endoscopic retrograde cholangiopancreatography (ERCP) be

38 MRCP obviated endoscopic retrograde cholangiopancreatography (ERCP) by

39 Difficult biliary cannulation in endoscopic retrograde cholangiopancreatography (ERCP) ca

40 eatic tissues to radiocontrast agents during endoscopic retrograde cholangiopancreatography (ERCP) ca

41 The role of diagnostic and therapeutic endoscopic retrograde cholangiopancreatography (ERCP) co

42 This method of biopsy and others, such as endoscopic retrograde cholangiopancreatography (ERCP) cy

43 ndings with histopathology/surgical findings/Endoscopic Retrograde CholangioPancreatography (ERCP) fi

44 Endoscopic ultrasonography (EUS) may replace endoscopic retrograde cholangiopancreatography (ERCP) fo

45 loon-assisted enteroscopy allows therapeutic endoscopic retrograde cholangiopancreatography (ERCP) in

46 Bile samples were obtained at endoscopic retrograde cholangiopancreatography (ERCP) in

47 Endoscopic retrograde cholangiopancreatography (ERCP) is

48 Endoscopic retrograde cholangiopancreatography (ERCP) is

49 struction can be performed endoscopically by endoscopic retrograde cholangiopancreatography (ERCP) or

50 creatic ductal anatomy evaluated by means of endoscopic retrograde cholangiopancreatography (ERCP) or

51 smitted by contaminated duodenoscopes during endoscopic retrograde cholangiopancreatography (ERCP) pr

52 ned in 34 patients with PSC established with endoscopic retrograde cholangiopancreatography (ERCP) we

53 an episode of choledocholithiasis requiring endoscopic retrograde cholangiopancreatography (ERCP) wi

54 Management often involves endoscopic retrograde cholangiopancreatography (ERCP) wi

55 Endoscopic retrograde cholangiopancreatography (ERCP) wi

56 ndoscopic ultrasonography (US), 21 patients; endoscopic retrograde cholangiopancreatography (ERCP), 1

57 ances of periduodenal perforation related to endoscopic retrograde cholangiopancreatography (ERCP), a

58 ancreatitis in high-risk patients undergoing endoscopic retrograde cholangiopancreatography (ERCP), b

59 n which MRCP was evaluated and compared with endoscopic retrograde cholangiopancreatography (ERCP), c

60 Comparison was made with findings at endoscopic retrograde cholangiopancreatography (ERCP), p

61 itis remains the most common complication of endoscopic retrograde cholangiopancreatography (ERCP), r

62 Endoscopic ultrasonography, endoscopic retrograde cholangiopancreatography (ERCP), s

63 asis is controversial, the 2-stage approach [endoscopic retrograde cholangiopancreatography (ERCP), s

64 Endoscopic retrograde cholangiopancreatography (ERCP), t

65 mary measured outcome was pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP).

66 hacin reduces the risk of pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP).

67 is the most common major complication after endoscopic retrograde cholangiopancreatography (ERCP).

68 n complication of diagnostic and therapeutic endoscopic retrograde cholangiopancreatography (ERCP).

69 of CBD stones before initiating therapeutic endoscopic retrograde cholangiopancreatography (ERCP).

70 ntial components of most current therapeutic endoscopic retrograde cholangiopancreatography (ERCP).

71 y reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP).

72 creening tool in all PSC patients undergoing endoscopic retrograde cholangiopancreatography (ERCP).

73 creases the occurrence of pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP).

74 scribed comparable accuracy when compared to endoscopic retrograde cholangiopancreatography (ERCP).

75 ict CBD stones and the need for preoperative endoscopic retrograde cholangiopancreatography (ERCP).

76 percutaneous, or endoscopic) have undergone endoscopic retrograde cholangiopancreatography (ERCP).

77 actable pain, and all patients had undergone endoscopic retrograde cholangiopancreatography for attem

78 rush samples from 272 patients who underwent endoscopic retrograde cholangiopancreatography for evalu

79 ndoscopic ultrasound are destined to replace endoscopic retrograde cholangiopancreatography for many

80 ens from 233 consecutive patients undergoing endoscopic retrograde cholangiopancreatography for pancr

81 ifically, we focus on the latest findings on endoscopic retrograde cholangiopancreatography for the e

82 e Swedish Registry for Gallstone Surgery and Endoscopic Retrograde Cholangiopancreatography (GallRiks

83 Patients who had an endoscopic retrograde cholangiopancreatography had fewer

84 tions associated with duodenoscopes used for endoscopic retrograde cholangiopancreatography have high

85 c ultrasonography (EUS) correlates well with endoscopic retrograde cholangiopancreatography in modera

86 gallbladder stenting and the performance of endoscopic retrograde cholangiopancreatography in patien

87 (brushings and/or endobiliary biopsy) during endoscopic retrograde cholangiopancreatography in the ab

88 Endoscopic retrograde cholangiopancreatography-induced a

89 well as the finding that diclofenac prevents endoscopic retrograde cholangiopancreatography-induced p

90 Endoscopic retrograde cholangiopancreatography is a non-

91 Endoscopic retrograde cholangiopancreatography is common

92 f TIPS and is likely to be overlooked unless endoscopic retrograde cholangiopancreatography is perfor

93 Endoscopic retrograde cholangiopancreatography is reserv

94 Advancements in the endoscopic retrograde cholangiopancreatography medical l

95 Endoscopic retrograde cholangiopancreatography mitigates

96 tomography, magnetic resonance (MR) imaging, endoscopic retrograde cholangiopancreatography, MR chola

97 tors in AC, evaluate the effect of timing of endoscopic retrograde cholangiopancreatography on clinic

98 se of ulinastatin for the prevention of post-endoscopic retrograde cholangiopancreatography pancreati

99 gabexate mesylate in the prevention of post-endoscopic retrograde cholangiopancreatography pancreati

100 d laparoscopically in experienced hands, and endoscopic retrograde cholangiopancreatography plays a d

101 Acute pancreatitis following endoscopic retrograde cholangiopancreatography presents

102 16 patients over the course of 40 weeks via endoscopic retrograde cholangiopancreatography procedure

103 le metallic stents (cSEMS) may require fewer endoscopic retrograde cholangiopancreatography procedure

104 ors such as toxins (alcohol), gallstones, or endoscopic retrograde cholangiopancreatography result in

105 The results of endoscopic retrograde cholangiopancreatography served as

106 ained in patients who underwent preoperative endoscopic retrograde cholangiopancreatography since the

107 Since the introduction of endoscopic retrograde cholangiopancreatography, there ha

108 In the validation cohort, timing of endoscopic retrograde cholangiopancreatography was not s

109 Initially, endoscopic retrograde cholangiopancreatography was purel

110 ed by elevated amylase or lipase levels, and endoscopic retrograde cholangiopancreatography was the m

111 s has replaced the diagnostic utilization of endoscopic retrograde cholangiopancreatography which is

112 loped cholangitis, necessitating an emergent endoscopic retrograde cholangiopancreatography with bili

113 ent was transferred to our hospital where an endoscopic retrograde cholangiopancreatography with bili

114 tients with choledocholithiasis treated with endoscopic retrograde cholangiopancreatography with lapa

115 We performed a randomized trial of endoscopic retrograde cholangiopancreatography with SOM

116 n, bile leak, retained stones, postoperative endoscopic retrograde cholangiopancreatography, wound in